World's Best Scientists 2026 revealed!
Margaret Hellard

Margaret Hellard

D-Index & Metrics

Immunology

D-Index
80
Citations
25917
World Ranking
1615
National Ranking
58

Medicine

D-Index
81
Citations
26404
World Ranking
16551
National Ranking
553

Margaret Hellard publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Margaret Hellard sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 716 publications — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Margaret Hellard D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Margaret Hellard sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 80 D-Index — 68th percentile

68% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2018 - Fellow of the Australian Academy of Health and Medical Science

Overview

Margaret Hellard is affiliated with the Burnet Institute in Australia and has contributed extensively to medical research, particularly within the fields of epidemiology, hepatology, and infectious diseases. Their work includes over 500 publications primarily focused on medicine and related subfields such as epidemiology, hepatology, infectious diseases, general health professions, and modeling and simulation.

Their research topics cover a broad spectrum, including:

  • Hepatitis C virus research
  • Hepatitis B virus studies
  • Liver disease diagnosis and treatment
  • HIV, drug use, sexual risk
  • HIV/AIDS research and interventions
  • COVID-19 epidemiological studies
  • Liver disease and transplantation

Frequent co-authors collaborating with Margaret Hellard include:

  • Mark Stoové
  • Joseph Doyle
  • Alisa Pedrana
  • Nick Scott
  • Rachel Sacks-Davis

Their research is regularly published in several academic journals. Major publication venues include:

  • International Journal of Drug Policy
  • Journal of Viral Hepatitis
  • Journal of Hepatology
  • The Medical Journal of Australia
  • BMJ Open

Among recent papers featuring their work or related research are:

  • "The Lancet Commission on lessons for the future from the COVID-19 pandemic", 2022, The Lancet
  • "A multinational Delphi consensus to end the COVID-19 public health threat", 2022, Nature
  • "Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis", 2021, The Lancet Public Health
  • "Consensus statement on the role of health systems in advancing the long-term well-being of people living with HIV", 2021, Nature Communications
  • "A global investment framework for the elimination of hepatitis B", 2020, Journal of Hepatology

Margaret Hellard has been recognized with awards such as the Fellowship of the Australian Academy of Health and Medical Science, awarded in 2018.

Best Publications

  • Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study.

    Unknown

  • Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees.

    Kate Dolan;Andrea L Wirtz;Babak Moazen;Martial Ndeffo-mbah

  • Hepatitis C Virus Treatment for Prevention Among People Who Inject Drugs: Modeling Treatment Scale-Up in the Age of Direct-Acting Antivirals

    Natasha K. Martin;Peter Vickerman;Jason Grebely;Margaret Hellard

  • Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission

    Graham S Cooke;Isabelle Andrieux-Meyer;Tanya L Applegate;Rifat Atun

  • Effects of Pre-exposure Prophylaxis for the Prevention of Human Immunodeficiency Virus Infection on Sexual Risk Behavior in Men Who Have Sex With Men: A Systematic Review and Meta-analysis

    Michael W Traeger;Michael W Traeger;Sophia E Schroeder;Sophia E Schroeder;Edwina J Wright;Margaret E Hellard;Margaret E Hellard

  • The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection

    Jason Grebely;Kimberly A Page;Rachel Sacks-Davis;Martin Schim van der Loeff

  • Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis

    Esther J Aspinall;Dhanya Nambiar;David J Goldberg;Matthew Hickman

  • SMS STI: a review of the uses of mobile phone text messaging in sexual health

    Megan S C Lim;Megan S C Lim;Jane S Hocking;Jane S Hocking;Margaret E Hellard;Margaret E Hellard;Campbell K Aitken

  • Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection.

    Michael W. Traeger;Vincent J. Cornelisse;Jason Asselin;Brian Price

  • Treatment of Hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis

    Esther J Aspinall;Stephen Corson;Joseph S Doyle;Joseph S Doyle;Joseph S Doyle;Jason Grebely

  • Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study

    Unknown

  • Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial.

    Jason Grebely;Olav Dalgard;Brian Conway;Evan B Cunningham

  • Hepatitis C Treatment for Injection Drug Users: A Review of the Available Evidence

    Margaret Hellard;Rachel Sacks-Davis;Judy Gold

  • Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine

    Jason Grebely;Maria Prins;Margaret Hellard;Andrea L Cox

  • A randomized, blinded, controlled trial investigating the gastrointestinal health effects of drinking water quality

    Margaret E. Hellard;Martha I. Sinclair;Andrew B. Forbes;Christopher K. Fairley

  • A systematic examination of the use of Online social networking sites for sexual health promotion

    Judy Gold;Judy Gold;Alisa Edith Pedrana;Alisa Edith Pedrana;Rachel Sacks-Davis;Rachel Sacks-Davis;Margaret Elena Hellard;Margaret Elena Hellard;Margaret Elena Hellard

  • Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection.

    Jason Grebely;Kathy Petoumenos;Margaret Hellard;Margaret Hellard;Gail V. Matthews;Gail V. Matthews

  • Impact of text and email messaging on the sexual health of young people: a randomised controlled trial

    Megan Su Cheng Lim;Jane Hocking;Campbell Kynoch Aitken;Christopher Kit Fairley

  • Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis

    Jack Stone;Hannah Fraser;Aaron G. Lim;Josephine G. Walker

  • What's in a message? Delivering sexual health promotion to young people in Australia via text messaging

    Judy Gold;Judy Gold;Megan Su Cheng Lim;Margaret Elena Hellard;Margaret Elena Hellard;Margaret Elena Hellard;Jane S Hocking

  • Eradication of hepatitis C infection: the importance of targeting people who inject drugs

    Margaret Elena Hellard;Joseph S Doyle;Rachel Sacks-Davis;Alexander J Thompson

  • Modelling antiviral treatment to prevent hepatitis C infection among people who inject drugs in Victoria, Australia

    Margaret E. Hellard;Rebecca Jenkinson;Peter Higgs;Mark A. Stoove;Mark A. Stoove

  • Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users

    Jason Grebely;Gail V. Matthews;Gail V. Matthews;Margaret Hellard;Margaret Hellard;David Shaw

Frequent Co-Authors

Mark Stoove
Mark Stoove Burnet Institute
Gregory J. Dore
Gregory J. Dore University of New South Wales
Megan S. C. Lim
Megan S. C. Lim Burnet Institute
Alexander J. Thompson
Alexander J. Thompson Ascension Health
Christopher K. Fairley
Christopher K. Fairley Monash University
Jason Grebely
Jason Grebely University of New South Wales
Gail V. Matthews
Gail V. Matthews University of New South Wales
Andrew R. Lloyd
Andrew R. Lloyd University of New South Wales
John M. Kaldor
John M. Kaldor University of New South Wales
Lisa Maher
Lisa Maher University of New South Wales

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing advanced healthcare degrees online can be a strategic move. Programs such as the best pmhnp programs online offer excellent clinical placement rates, ensuring practical experience alongside theoretical knowledge. These programs are ideal for students aiming to specialize in psychiatric nursing while balancing other commitments.

Cost is often a concern when selecting an online program. Fortunately, cheap psych np programs provide affordable pathways without compromising quality, making advanced education accessible to a wider range of students.

Understanding financial outcomes is critical when planning a career. Those who earn Doctor of Nursing Practice degrees typically have varied salaries depending on location. For insight, the how much do dnps make guide offers valuable state-by-state salary information, helping graduates make informed decisions.

For nurses looking to refine their scope, transitioning roles can open new opportunities. The resource on fnp to acute care np steps nurses through career advancement from family nursing to specialized acute care, highlighting the importance of continuing education and certification.

Best Scientists Citing Margaret Hellard

Trending Scientists

Recently Published Articles